𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reversible spastic and pyramidal tract signs in a patient with parkinson's disease on L-Dopa

✍ Scribed by Sepp Seyfert; Max Straschill

Publisher
Springer
Year
1977
Tongue
English
Weight
201 KB
Volume
216
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simultaneous MAO-B and COMT inhibition i
Simultaneous MAO-B and COMT inhibition in L-dopa-treated patients with parkinson's disease
✍ Dr. Jukka Lyytinen; Seppo Kaakkola; Sirpa Ahtila; Päivi Tuomainen; Heikki Terävä 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 801 KB

## Abstract The effect of selegiline (L‐deprenyl) on plasma catecholamines, clinical response, and drug tolerability was studied in 13 patients with Parkinson's disease (PD) treated with L‐Dopa/benserazide and entacapone, a peripheral catechol‐__O__‐methyltransferase (COMT) inhibitor, in a placebo‐

Idazoxan, an alpha-2 antagonist, and L-D
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
✍ O. Rascol; I. Arnulf; H. Peyro-Saint Paul; C. Brefel-Courbon; M. Vidailhet; C. T 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

## Abstract Dyskinesia is a frequent and disabling side effect in patients with Parkinson's disease treated with chronic dopatherapy. Preclinical data in the 1‐methyl‐4‐phenyl‐1,2,3,6,‐tetrahydropyridine (MPTP) monkey suggest that alpha‐2 antagonists may reduce dihydroxyphenylalanine (L‐DOPA)‐induc

Intravenous boluses and continuous infus
Intravenous boluses and continuous infusions of L-DOPA methyl ester in fluctuating patients with Parkinson's disease
✍ Dr. F. Stocchi; S. Ruggieri; A. Carta; J. Ryatt; N. Quinn; P. Jenner; C. D. Mars 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

## Abstract In six patients with Parkinson's disease exhibiting severe “on‐off” phenomena, a 200‐mg intravenous bolus of either L‐DOPA or of its methyl ester were equally effective in reversing motor deficits, although the duration of action of the methyl ester was shorter. There were no marked dif

Dopa-responsive dystonia and early-onset
Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency?
✍ Lena Elisabeth Hjermind; Lis Gitte Johannsen; Nenad Blau; Ron Allan Wevers; Chri 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

We describe a patient with a combination of dystonic and parkinsonian signs. Paraclinical studies revealed a mutation in the GTP cyclohydrolase I gene (GCH1) and a decrease in [ 123 I]-N--fluoropropyl-2␤-carbomethoxy-3␤-(4iodophenyl) nortropane ( 123 I-FP-CIT) binding ratios indicative of Parkinson'